|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$201,782,322 |
|
|
Indirect Value
|
$171,213,609 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
798,767 |
|
- |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-20 |
4 |
S |
$3.14 |
$13,188 |
I/I |
(4,200) |
800,191 |
0 |
% |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2019-05-13 |
4 |
B |
$1.99 |
$20,991 |
I/I |
10,572 |
801,817 |
1.5 |
- |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-19 |
4 |
S |
$3.22 |
$13,714 |
I/I |
(4,259) |
804,391 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-18 |
4 |
S |
$3.35 |
$46,304 |
I/I |
(13,822) |
808,650 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-17 |
4 |
S |
$3.34 |
$84,646 |
I/I |
(25,343) |
822,472 |
0 |
% |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2019-05-20 |
4 |
B |
$1.93 |
$65,376 |
I/I |
33,900 |
835,717 |
1.5 |
- |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-14 |
4 |
S |
$3.20 |
$9,600 |
I/I |
(3,000) |
847,815 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-13 |
4 |
S |
$2.88 |
$8,640 |
I/I |
(3,000) |
850,815 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-12 |
4 |
S |
$2.85 |
$3,420 |
I/I |
(1,200) |
853,815 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-11 |
4 |
S |
$2.96 |
$2,664 |
I/I |
(900) |
855,015 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-07 |
4 |
S |
$2.90 |
$580 |
I/I |
(200) |
855,915 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2022-10-06 |
4 |
S |
$2.96 |
$14,507 |
I/I |
(4,901) |
856,115 |
0 |
% |
|
SRCL |
Stericycle Inc |
Director |
|
2013-03-25 |
4 |
S |
$103.92 |
$96,126 |
D/D |
(925) |
860,216 |
0 |
- |
|
SRCL |
Stericycle Inc |
Director |
|
2012-12-19 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,521 |
861,141 |
0 |
- |
|
SRCL |
Stericycle Inc |
Director |
|
2012-12-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
212,000 |
864,662 |
0 |
- |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2023-10-06 |
4 |
S |
$0.30 |
$11,448 |
I/I |
(37,931) |
872,956 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2021-02-03 |
4 |
B |
$12.25 |
$1,242,150 |
I/I |
101,400 |
895,035 |
1.5 |
% |
|
TTHI |
Transition Therapeutics |
10% Owner |
|
2010-12-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
897,084 |
|
- |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2023-10-05 |
4 |
S |
$0.30 |
$3,216 |
I/I |
(10,670) |
910,887 |
0 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2023-10-04 |
4 |
S |
$0.31 |
$12,867 |
I/I |
(41,399) |
921,557 |
0 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-01-09 |
4 |
B |
$19.00 |
$6,447,992 |
I/I |
339,368 |
952,678 |
2.25 |
- |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2023-05-05 |
4 |
B |
$2.98 |
$999,999 |
I/I |
335,570 |
962,956 |
0.01 |
% |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2003-11-21 |
4 |
B |
$35.29 |
$229,700 |
D/D |
6,500 |
1,021,664 |
2.39 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
10% Owner |
|
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,044,578 |
1,044,578 |
0 |
- |
|
634 Records found
|
|
Page 8 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|